Eclipsebio Acquires Terrain Bio to Expand Its End-to-End AI Platform for the Design, Manufacturing, and Validation of RNA Therapeutics ...

SHANGHAI, SHANGHAI, CHINA, January 20, 2026 /EINPresswire.com/ -- The global healthcare sector is witnessing a paradigm ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

Optimizing drug delivery to the lymphatic system is essential for effective cancer treatment, as lymph node (LN) metastasis ...

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

The future of engineering-driven health innovation is currently unfolding at Arizona State University. In the School of Biological and Health Systems Engineering, part of the Ira A. Fulton Schools of ...

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- As healthcare moves toward proactive and at-home ...

Scientists can now design fully synthetic bacteriophages, with potential to reshape the fight against antibiotic resistance.

Psychedelic therapy isn’t just about the drug; it’s about the dose, too. Here's why the overlooked middle ground may matter more than we think.

The lower hinge of immunoglobulin G (IgG), an overlooked part of the antibody, acts as a structural and functional control hub, according to a study by researchers at Science Tokyo. Deleting a single ...

An evidence-informed, AI-enabled daily contemplative practice to help people actively shape their whole-person health ...